Target intelligence / Profile preview

Phosphatidylinositol 3-kinase catalytic subunit beta (PI3K-beta (p110β))

Target
PI3K-beta (p110β)
Molecular classification
Enzyme (lipid kinase), Kinase (phosphoinositide 3-kinase, Class I), Signal transduction protein
01

Overview

Phosphatidylinositol 3-kinase catalytic subunit beta is the Class IA PI3K catalytic isoform p110β that heterodimerizes with p85-type regulatory subunits to phosphorylate phosphatidylinositol 4,5-bisphosphate at the 3-position, generating PIP3 and initiating AKT-dependent signaling cascades that regulate cell growth, proliferation, survival, metabolism, motility, and angiogenesis. It has a unique role in controlling DNA replication through both kinase-dependent signaling (nuclear AKT activation affecting p21Cip and PCNA) and kinase-independent interactions with PCNA that regulate its loading onto chromatin. PI3Kβ also interfaces with GPCR signaling via direct regulation by Gβγ, highlighting its integration of RTK and GPCR inputs within Class I PI3K signaling networks.

Other names
p110βPI3KβClass IA PI3K beta catalytic subunitPhosphoinositide 3-kinase beta catalytic subunit
02

Mechanism of action

Competitive inhibition of the ATP-binding site of PI3K catalytic subunits to block PIP3 production, thereby downregulating AKT/PDK1 signaling and downstream proliferative/survival pathways. Isoform-selective inhibition of Class I PI3Ks to modulate specific cellular functions; structural features enable design of isoform-specific inhibitors.

03

Biological functions

Signal transduction via PI3K–AKT–mTOR pathwayGeneration of phosphatidylinositol 3,4,5-trisphosphate (PIP3) from PI(4,5)P2Regulation of cell growth, survival, proliferation, metabolism, motility, and angiogenesis through downstream effectors (AKT/PDK1/mTOR, MAPKs, NF-κB, JNK)Control of DNA replication and S-phase progression (PCNA loading; nuclear AKT activation) specific to PI3KβGPCR-integrated PI3K signaling (PI3Kβ activation by Gβγ)
04

Disease associations

Cancer (PI3K pathway oncogenic activation; PI3Kβ implicated in proliferation and cell-cycle control)Cardiovascular/angiogenesis roles via endothelial signalingImmune signaling cross-talk (via PI3K pathway effectors)
05

Safety considerations

Class-wide PI3K inhibition can impact metabolism, immune function, and survival signaling given the pathway’s broad roles; careful therapeutic window and isoform selectivity are importantPotential on-target effects on cell cycle and DNA replication when inhibiting PI3Kβ-specific functions
06

Interacting drugs

Pan-PI3K inhibitors used in cancer therapeutics (class examples discussed include PI3K inhibitors targeting PI3K isoforms)

1 more in the full profile.

07

Biomarkers

Activation markers of the PI3K pathway such as phosphorylated AKT or downstream readouts (used to monitor PI3K pathway inhibition)Note: PI3K pathway genomic alterations are widely used in oncology, but the provided sources do not specify PIK3CB-specific biomarkers; inference limited to pathway activity markers

Beyond the preview

Go deeper on Phosphatidylinositol 3-kinase catalytic subunit beta (PI3K-beta (p110β)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phosphatidylinositol 3-kinase catalytic subunit beta (PI3K-beta (p110β)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call